BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6306098)

  • 1. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA; Wood JM; Folkers C; Schild GC
    Epidemiol Infect; 1988 Jun; 100(3):501-10. PubMed ID: 2837409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
    Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
    Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
    Bogdan JR; Morley PS; Townsend HG; Haines DM
    Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine.
    Wood JM; Mumford J; Folkers C; Scott AM; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):371-84. PubMed ID: 6345659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.
    Mumford JA; Wilson H; Hannant D; Jessett DM
    Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of circulating antibody and immunity following infection with equine influenza virus.
    Hannant D; Mumford JA; Jessett DM
    Vet Rec; 1988 Feb; 122(6):125-8. PubMed ID: 2835850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
    Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
    Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses.
    Wattrang E; Jessett DM; Yates P; Fuxler L; Hannant D
    Viral Immunol; 2003; 16(1):57-67. PubMed ID: 12725689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.